I went in today (2 Feb 2024). There is nothing much that I could do now. Just wait until end of February to see whether its quarter results is good enough or not. Bears are in full control now.
The long tail below the body is indicative of sellers trying to push the price down by a significant amount but the buyers manage to push it back up. The buyers do this to show a definitive buying strength which will lead to an increase in price, going forward.
KAREX is riding on the strong growth in the condom industry, focusing on high-margin products which will take its profitability to a higher level. It is penetrating high-growth markets with premium offerings backed by innovation and strict compliance with international standards. We project its earnings to double in FY24, followed by another 88% surge in FY25. We initial coverage on KAREX with an OUTPERFORM rating and a TP of RM1.00.
Read and listen to the words from Karex CEO. "Karex pivots beyond latex condoms". Results have been better quarter over quarter for 5 consecutive quarters. He said 26 Feb 2024 will also be better than the previous quarter. New products are lubricant and gloves.
Please understand that RM0.87 at this moment is not Karex all time high. Its all time high was RM3.10 on 11.3.2016. It is unlike Sunway, MBMR, HUMEIND, etc.
The heyday of being the sole and top condom manufacturer in Malaysia is over for Karex Bhd. I used to own a significant number of Karex shares, but it saddens me that the management has failed to turn the company around even after many years. I don't believe Karex will recover to its previous highs
Agree with Kenanga's analyst with regards to the emphasis on improving margins by the company. However, the focus on premium products is not really feasible cause condom users do not place much importance on the actual quality of the products compared to other consumer staples. There is no way for the company to bring the sales volume/total sales back to 2016 levels because the competition within the condom market is surging. Despite the recent introduction of abortion laws in the US, there isn't any significant uptick in sales for the US market which is a bit disappointing.
However, there still remains a few tailwinds for the condom market and near-term catalysts for Karex. Such as weaker Ringgit, and the stabilisation of raw material/labour cost. And the diversification/venture into gloves and lubricant products, on top of the company's healthy balance sheet.
Consolidation shall finished.. $1.06 kenanga target coming.. KAREX is the largest condom Mfg in the world.. It need to reflect its strength but not below $1 penny world class
this stock.. if you look at recent times, low 80+ sen has been a good support level. then slowly inch up closer to results... post result, come back down. cycle repeats. granted, the results so far has showed major turnaround already .. and the next rerating catalyst will come from the company saying it started mass production for its new product.. and selling big time to the big brand. then.. got chance to see RM1. wait and see ba.
2025 shld be the year karex shines.. *fingers crossed* 🤞🤞 looking forward to new synthetic product contributing in a material way ... earnings likely come in toward 2nd half 2025.. but maybe price will reflect first, being leading indicator... insya-Allah..
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Tryingtogetrich
164 posts
Posted by Tryingtogetrich > 2023-11-24 15:38 | Report Abuse
001 condoms are by karex? I thought there are by Okamoto. One condom released a Graphene condom 1 month ago is US